Sodium Channel Blockers
Showing 1 - 25 of 4,910
Therapeutic Drug Use for CKD Patients
Active, not recruiting
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
-
Jinan, Shandong, ChinaXiao Li，MD
Apr 18, 2023
Sodium Channel Mutations in Anterior Cutaneous Nerve Entrapment
Not yet recruiting
- Anterior Cutaneous Nerve Entrapment Syndrome
- +2 more
- Sodium channel mutation
-
Veldhoven, NetherlandsMaxima Medical Center
May 26, 2023
Essential Hypertension Trial (Azilsartan Medoxomil Potassium Tablet, Nifedipine Sustained -release Tablets, Levoamlodipine
Not yet recruiting
- Essential Hypertension
- Azilsartan Medoxomil Potassium Tablet
- +2 more
- (no location specified)
Jul 21, 2023
Long-term Use of CCB and Breast Cancer Risk
Active, not recruiting
- Hypertension,Essential
- Breast Cancer
- Calcium channel blocker
- +5 more
-
Bentley, Western Australia, AustraliaCurtin university
Aug 1, 2023
Pain Trial in Vienna (Room temperature, Cold temperature, Lidocain)
Not yet recruiting
- Pain
- Room temperature
- +6 more
-
Vienna, AustriaMedical University of Vienna
Jul 6, 2023
ive Alzheimer's Medicines- Dihydropyridine Calcium Channel
Active, not recruiting
- Hypertension
- Dihydropyridine calcium channel blocker
- Hydrochlorothiazide
-
Boston, MassachusettsBrigham and Women's Hospital
Mar 1, 2022
Angiotensin Converting Enzyme Inhibitors and Angiotensin
Not yet recruiting
- COVID-19 Pneumonia
- Covid_19
- (no location specified)
Jun 5, 2022
Long QT Syndrome Trial in Rochester (Placebo, Ranolazine)
Completed
- Long QT Syndrome
- Placebo
- Ranolazine
-
Rochester, New YorkUniversity of Rochester
Mar 15, 2022
Potassium Sodium-Activated Channel Subfamily T Member 1-Related
Active, not recruiting
- KCNT1-Related Epilepsy
- No Intervention
-
Rochester, New YorkUniversity of Rochester
Jan 12, 2023
Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in Dallas (Angiotensin II Receptor Blockers
Recruiting
- Cognitively Normal Older Adults
- +3 more
- Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
- PCP
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Dec 1, 2022
HIV, Cardiovascular Diseases, Hypertension Trial in United States (Indinavir sulfate, Ritonavir, Amlodipine)
Completed
- HIV Infections
- +2 more
- Indinavir sulfate
- +3 more
-
San Francisco, California
- +8 more
Oct 28, 2021
Crohn's Disease, Inflammatory Bowel Disease Trial in Nashville (Ranolazine, Placebo)
Enrolling by invitation
- Crohn's Disease
- Inflammatory Bowel Disease
- Ranolazine
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
May 20, 2022
Hypertension Trial in Beijing, Zoucheng, ShenZhen (Protocol initiate with A, Protocol initiate with C, Protocol initiate with D)
Recruiting
- Hypertension
- Protocol initiate with A
- +2 more
-
Beijing, Henan, China
- +2 more
Apr 14, 2021
Endoscopic Sinus Surgery Trial in Cairo (Dexmedetomidine, Melatonin, Pregabalin)
Not yet recruiting
- Endoscopic Sinus Surgery
- Dexmedetomidine
- +3 more
-
Cairo, EgyptAl-Azhar University hospitals
Apr 24, 2023
Hypertension Trial in Thessaloniki, London (Anti-hypertensive Medication -)
Completed
- Hypertension
- Anti-hypertensive Medication -
-
Thessaloniki, Greece
- +1 more
Mar 5, 2021
Beta Blocker Toxicity Trial in Tanta (nonselective beta blocker, cardio-selective beta blocker group, alendronate sodium)
Recruiting
- Beta Blocker Toxicity
- nonselective beta blocker
- +2 more
-
Tanta, EgyptSherief Abd-Elsalam
Jan 9, 2021
Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2
Recruiting
- Diabetes Mellitus
- Cardiovascular Diseases
- Renin-angiotensin-aldosterone system inhibitors
- +2 more
-
Singapore, SingaporeSingapore General Hospital (SGH)
Apr 28, 2021
Hypertension, Coronary Atherosclerosis Trial in Tokyo (Calcium channel blockers (amlodipine, azelnidipine))
Completed
- Hypertension
- Coronary Atherosclerosis
- Calcium channel blockers (amlodipine, azelnidipine)
-
Tokyo, JapanDepartment of Cardiology, Juntendo University School of Medicine
May 12, 2021
Glomerulonephritis, Immunoglobulin A Nephropathy Trial (Corticosteroid, Renin-angiotensin sytem blockers, Sodium-glucose
Not yet recruiting
- Glomerulonephritis
- Immunoglobulin A Nephropathy
- Corticosteroid
- +2 more
- (no location specified)
Oct 13, 2021
The Efficacy of Nifedipine in the Management of Preterm Labor
Not yet recruiting
- Preterm Labor
- +5 more
- Nifedipine 10 mg
- (no location specified)
Nov 19, 2020
Breast Cancer, Cardiotoxicity Trial in United States (antihypertensive medications, Blood pressure measurement, Echocardiogram)
Recruiting
- Breast Cancer
- Cardiotoxicity
- antihypertensive medications
- +5 more
-
Basking Ridge, New Jersey
- +6 more
Aug 29, 2023
Primary Aldosteronism, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral) Trial in Boston (Amlodipine)
Recruiting
- Primary Aldosteronism
- Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
-
Boston, MassachusettsAnand Vaidya
Nov 26, 2021
Raynaud Disease, Systemic Sclerosis, Digital Ulcer Trial in Seoul (Calcium Channel Blockers, Phosphodiesterase Inhibitors,
Terminated
- Raynaud Disease
- +2 more
- Calcium Channel Blockers
- +4 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 8, 2020
Depolarising Electrical Skin Stimulation in Neuropathic and
Recruiting
- Neuropathy;Peripheral
- neurophysiology
-
Nottwil, SwitzerlandCentre for Pain Medicine
Oct 31, 2022
Anesthesia Intubation Complication Trial in Zagazig (Nebulized Dexmedetomidine, Nebulized Lidocaine, Intravenous
Not yet recruiting
- Anesthesia Intubation Complication
- Nebulized Dexmedetomidine
- +3 more
-
Zagazig, Al-Sharkia, EgyptFaculty of medicine, Zagazig University
Jul 4, 2023